Aratana Therapeutics Inc (NASDAQ:PETX)

13.41
Delayed Data
As of May 22
 -0.10 / -0.74%
Today’s Change
9.20
Today|||52-Week Range
20.63
-24.75%
Year-to-Date
No recent news for Aratana Therapeutics Inc.

Today’s Trading

Previous close13.51
Today’s open13.53
Day’s range13.25 - 13.74
Volume83,707
Average volume (3 months)245,906
Market cap$468.1M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)-233.33%
Earnings growth (this year)-15.67%
Earnings growth (next 5 years)+9.06%
Revenue growth (last year)+523.58%
P/E ratioNM
Price/Sales691.60
Price/Book2.52

Competitors

 Today’s
change
Today’s
% change
SCLNSciClone Pharmaceuti...+0.14+1.51%
SRNESorrento Therapeutic...-0.27-2.04%
PRQRProQR Therapeutics N...-0.14-0.71%
LBIOLion Biotechnologies...+0.10+0.94%
Data as of 4:14pm ET, 05/22/2015

Financials

Next reporting dateAugust 11, 2015
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$767.0K
Annual profit (last year)-$38.8M
Net profit margin-5,060.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Steven St. Peter
Chief Financial Officer &
Treasurer
Craig A. Tooman
Corporate headquarters
Kansas City, Kansas

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers